Tower Cancer Research Foundation Integrates Work and Assets of the Dr. Susan Love Foundation for Breast Cancer Research and Announces Visionary New CEO Christopher Clinton Conway
Retrieved on:
Thursday, January 25, 2024
Senior, Patient, Research, Project Angel Food, CHLA, Doheny Eye Institute, MD–PhD, TCRF, Diagnosis, Palliative care, Joffrey, Survivor, Breast cancer, AI, Woman, Cancer, Work, Breast Cancer Research, Disease, UCLA, Acceleration, Renzo, Ballet company, Career development, FDA, Magnolia, Marketing, Nobel Peace Prize, Bangladesh Technical Education Board, LACMA, Carter Center, Korn Ferry, Estate (law)
Conway brings a wealth of philanthropic and executive leadership experience and counsel, and a passion for changing the course of cancer.
Key Points:
- Conway brings a wealth of philanthropic and executive leadership experience and counsel, and a passion for changing the course of cancer.
- TCRF's Board of Directors voted in early January 2024 to integrate the work and assets of Dr. Susan Love (1948-2023), founder and Chief Visionary Officer of the Dr. Susan Love Foundation for Breast Cancer Research, into TCRF.
- Dr. Love was an internationally renowned and compassionate trailblazer in the work to end breast cancer.
- TCRF is now at the forefront of this work, extending its reach by establishing the Dr. Susan Love Fund for Breast Cancer Research .